PTCT vs. MATX
PTCT (PTC Therapeutics, Inc.) and MATX (Matson, Inc.) are both stocks. PTCT operates in Biotechnology (Healthcare), while MATX operates in Marine Shipping (Industrials). Over the past 10 years, PTCT returned 24.54%/yr vs 21.00%/yr for MATX. At a 0.23 correlation, their price movements are largely independent.
Performance
PTCT vs. MATX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PTCT achieves a -9.58% return, which is significantly lower than MATX's 51.02% return. Over the past 10 years, PTCT has outperformed MATX with an annualized return of 24.54%, while MATX has yielded a comparatively lower 21.00% annualized return.
PTCT
- 1D
- 0.66%
- 1M
- 4.87%
- YTD
- -9.58%
- 6M
- -9.35%
- 1Y
- 35.49%
- 3Y*
- 15.90%
- 5Y*
- 11.88%
- 10Y*
- 24.54%
MATX
- 1D
- -0.67%
- 1M
- 8.98%
- YTD
- 51.02%
- 6M
- 63.44%
- 1Y
- 65.56%
- 3Y*
- 38.38%
- 5Y*
- 25.84%
- 10Y*
- 21.00%
PTCT vs. MATX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PTCT PTC Therapeutics, Inc. | -9.58% | 68.28% | 63.79% | -27.80% | -4.17% | -34.74% | 27.07% | 39.95% | 105.76% | 52.89% |
MATX Matson, Inc. | 51.02% | -7.21% | 24.30% | 78.20% | -29.53% | 60.35% | 43.05% | 30.32% | 9.78% | -13.51% |
Correlation
The correlation between PTCT and MATX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jun 21, 2013 | 0.23 |
Fundamentals
PTCT:
$5.67B
MATX:
$5.69B
PTCT:
-$2.27
MATX:
$13.63
PTCT:
6.82
MATX:
1.76
PTCT:
$827.11M
MATX:
$3.32B
PTCT:
$410.90M
MATX:
$610.50M
PTCT:
-$38.52M
MATX:
$712.90M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PTCT vs. MATX — Risk / Return Rank
PTCT
MATX
PTCT vs. MATX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PTC Therapeutics, Inc. (PTCT) and Matson, Inc. (MATX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PTCT | MATX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.98 | ||
| Sortino ratioReturn per unit of downside risk | -1.22 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.33 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.31 | 2.74 | -1.43 |
| Martin ratioReturn relative to average drawdown | 2.72 | 8.45 | -5.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PTCT | MATX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | 1.83 | -0.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 0.65 | -0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.50 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.25 | -0.09 |
Drawdowns
PTCT vs. MATX - Drawdown Comparison
The maximum PTCT drawdown since its inception was -94.60%, which is greater than MATX's maximum drawdown of -71.40%. Use the drawdown chart below to compare losses from any high point for PTCT and MATX.
Loading charts...
Drawdown Indicators
| PTCT | MATX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.60% | -71.40% | -23.20% |
Max Drawdown (1Y)Largest decline over 1 year | -27.17% | -24.05% | -3.12% |
Max Drawdown (3Y)Largest decline over 3 years | -59.86% | -46.90% | -12.96% |
Max Drawdown (5Y)Largest decline over 5 years | -69.42% | -53.63% | -15.79% |
Max Drawdown (10Y)Largest decline over 10 years | -73.78% | -53.63% | -20.15% |
Current DrawdownCurrent decline from peak | -20.37% | -1.49% | -18.88% |
Average DrawdownAverage peak-to-trough decline | -46.09% | -33.33% | -12.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.09% | 7.78% | +5.31% |
Volatility
PTCT vs. MATX - Volatility Comparison
PTC Therapeutics, Inc. (PTCT) has a higher volatility of 18.71% compared to Matson, Inc. (MATX) at 12.96%. This indicates that PTCT's price experiences larger fluctuations and is considered to be riskier than MATX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PTCT | MATX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.71% | 12.96% | +5.75% |
Volatility (6M)Calculated over the trailing 6-month period | 29.23% | 24.89% | +4.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.80% | 36.00% | +5.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.86% | 39.74% | +15.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.56% | 42.19% | +24.37% |
Dividends
PTCT vs. MATX - Dividend Comparison
PTCT has not paid dividends to shareholders, while MATX's dividend yield for the trailing twelve months is around 0.77%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MATX Matson, Inc. | 0.77% | 1.13% | 0.98% | 1.15% | 1.95% | 1.18% | 1.58% | 2.11% | 2.56% | 2.61% | 2.09% | 1.64% |
PTCT PTC Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PTCT vs. MATX - Financials Comparison
This section allows you to compare key financial metrics between PTC Therapeutics, Inc. and Matson, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PTCT vs. MATX - Profitability Comparison
PTCT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, PTC Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 272.55M. Therefore, the gross margin over that period was 0.0%.
MATX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Matson, Inc. reported a gross profit of 0.00 and revenue of 757.80M. Therefore, the gross margin over that period was 0.0%.
PTCT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, PTC Therapeutics, Inc. reported an operating income of 44.96M and revenue of 272.55M, resulting in an operating margin of 16.5%.
MATX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Matson, Inc. reported an operating income of 61.40M and revenue of 757.80M, resulting in an operating margin of 8.1%.
PTCT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, PTC Therapeutics, Inc. reported a net income of -2.81M and revenue of 272.55M, resulting in a net margin of -1.0%.
MATX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Matson, Inc. reported a net income of 56.60M and revenue of 757.80M, resulting in a net margin of 7.5%.
Frequently Asked Questions
PTCT and MATX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PTCT has higher volatility (18.71%) compared to MATX (12.96%). In terms of maximum drawdown, PTCT dropped -94.60% vs MATX's -71.40%.
MATX currently has the higher Sharpe Ratio (1.83 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PTCT and MATX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer